BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37370869)

  • 1. PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature.
    Evangelista L; Fiz F; Laudicella R; Bianconi F; Castello A; Guglielmo P; Liberini V; Manco L; Frantellizzi V; Giordano A; Urso L; Panareo S; Palumbo B; Filippi L
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-radiomics in cancer immunotherapy response prediction: A systematic review.
    Abbas E; Fanni SC; Bandini C; Francischello R; Febi M; Aghakhanyan G; Ambrosini I; Faggioni L; Cioni D; Lencioni RA; Neri E
    Eur J Radiol Open; 2023 Dec; 11():100511. PubMed ID: 37520768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.
    Dercle L; McGale J; Sun S; Marabelle A; Yeh R; Deutsch E; Mokrane FZ; Farwell M; Ammari S; Schoder H; Zhao B; Schwartz LH
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.
    Lin Q; Wu HJ; Song QS; Tang YK
    Front Oncol; 2022; 12():937277. PubMed ID: 36267975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
    Monaco L; De Bernardi E; Bono F; Cortinovis D; Crivellaro C; Elisei F; L'Imperio V; Landoni C; Mathoux G; Musarra M; Pagni F; Turolla EA; Messa C; Guerra L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3401-3411. PubMed ID: 35403860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
    Farina B; Guerra ADR; Bermejo-Peláez D; Miras CP; Peral AA; Madueño GG; Jaime JC; Vilalta-Lacarra A; Pérez JR; Muñoz-Barrutia A; Peces-Barba GR; Maceiras LS; Gil-Bazo I; Gómez MD; Ledesma-Carbayo MJ
    J Transl Med; 2023 Mar; 21(1):174. PubMed ID: 36872371
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Polverari G; Ceci F; Bertaglia V; Reale ML; Rampado O; Gallio E; Passera R; Liberini V; Scapoli P; Arena V; Racca M; Veltri A; Novello S; Deandreis D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
    Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
    Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian imaging radiomics quality score assessment: an EuSoMII radiomics auditing group initiative.
    Ponsiglione A; Stanzione A; Spadarella G; Baran A; Cappellini LA; Lipman KG; Van Ooijen P; Cuocolo R
    Eur Radiol; 2023 Mar; 33(3):2239-2247. PubMed ID: 36303093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
    Valentinuzzi D; Vrankar M; Boc N; Ahac V; Zupancic Z; Unk M; Skalic K; Zagar I; Studen A; Simoncic U; Eickhoff J; Jeraj R
    Radiol Oncol; 2020 Jul; 54(3):285-294. PubMed ID: 32726293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of machine learning-based radiomics approach for predicting microsatellite instability status in colorectal cancer.
    Wang Q; Xu J; Wang A; Chen Y; Wang T; Chen D; Zhang J; Brismar TB
    Radiol Med; 2023 Feb; 128(2):136-148. PubMed ID: 36648615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of the radiomics quality score applications: an EuSoMII Radiomics Auditing Group Initiative.
    Spadarella G; Stanzione A; Akinci D'Antonoli T; Andreychenko A; Fanni SC; Ugga L; Kotter E; Cuocolo R
    Eur Radiol; 2023 Mar; 33(3):1884-1894. PubMed ID: 36282312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac CT and MRI radiomics: systematic review of the literature and radiomics quality score assessment.
    Ponsiglione A; Stanzione A; Cuocolo R; Ascione R; Gambardella M; De Giorgi M; Nappi C; Cuocolo A; Imbriaco M
    Eur Radiol; 2022 Apr; 32(4):2629-2638. PubMed ID: 34812912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
    Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
    Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and quality of radiomics studies in lymphoma: a systematic review.
    Wang H; Zhou Y; Li L; Hou W; Ma X; Tian R
    Eur Radiol; 2020 Nov; 30(11):6228-6240. PubMed ID: 32472274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review.
    Wu L; Lou X; Kong N; Xu M; Gao C
    Eur Radiol; 2023 Mar; 33(3):2105-2117. PubMed ID: 36307554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.